CONCI, NICOLE
 Distribuzione geografica
Continente #
NA - Nord America 185
EU - Europa 148
AS - Asia 54
AF - Africa 22
OC - Oceania 3
Totale 412
Nazione #
US - Stati Uniti d'America 185
IT - Italia 53
VN - Vietnam 31
SE - Svezia 26
DE - Germania 25
GB - Regno Unito 13
IE - Irlanda 13
IN - India 10
TG - Togo 10
CI - Costa d'Avorio 6
CN - Cina 6
NG - Nigeria 6
JO - Giordania 5
CH - Svizzera 4
ES - Italia 4
FI - Finlandia 4
AU - Australia 3
JP - Giappone 2
RU - Federazione Russa 2
BE - Belgio 1
FR - Francia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 412
Città #
Dong Ket 30
Chandler 27
Ashburn 18
Fairfield 17
Seattle 17
Woodbridge 14
Dublin 13
Southend 11
Bologna 10
Houston 10
Lomé 10
Wilmington 9
Cambridge 8
Princeton 8
Moncalieri 7
Abeokuta 6
Abidjan 6
Amman 5
Rome 5
Berlin 4
Bern 4
Helsinki 4
Seville 4
Bremen 3
Redmond 3
San Diego 3
Borgomanero 2
Des Moines 2
Jinan 2
Manchester 2
Melbourne 2
Saitama 2
Ann Arbor 1
Beijing 1
Boydton 1
Brussels 1
Canberra 1
Chicago 1
Chions 1
Falkenstein 1
Genova 1
Hamburg 1
Hangzhou 1
Hanoi 1
Mülheim 1
Ningbo 1
Olalla 1
Redwood City 1
Reggio Nell'emilia 1
San Francisco 1
Secaucus 1
Trieste 1
Turin 1
Udine 1
Westminster 1
Totale 291
Nome #
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 175
The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter 92
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors 55
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. 46
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 31
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis 26
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? 5
Totale 430
Categoria #
all - tutte 1.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 1 10 5 7 1 2
2020/2021109 4 2 1 1 34 23 1 1 3 2 1 36
2021/2022102 3 0 2 3 5 3 0 22 9 8 30 17
2022/2023158 13 29 7 16 15 9 4 11 31 3 9 11
2023/202435 7 10 3 5 7 3 0 0 0 0 0 0
Totale 430